• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在持续性非卧床腹膜透析腹膜炎的长期随访中,肿瘤坏死因子-α、白细胞介素-6和前列腺素与大分子物质腹膜通透性的关系

Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.

作者信息

Zemel D, Koomen G C, Hart A A, ten Berge I J, Struijk D G, Krediet R T

机构信息

Department of Medicine, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

J Lab Clin Med. 1993 Dec;122(6):686-96.

PMID:8245688
Abstract

Infectious reactions are known to comprise changes in vasopermeability and inflammatory mediators. We used peritonitis that complicated continuous ambulatory peritoneal dialysis (CAPD) as an in vivo inflammation model to study the time courses of peritoneal permeability characteristics and mediators in dialysate. Sixteen episodes of peritonitis were prospectively followed on eight consecutive days from the onset of the infection and once after recovery (control). Dialysate night dwells were examined for marker proteins of peritoneal permeability, cytokines (tumor necrosis factor-alpha [TNF-alpha], interleukin-6 [IL-6] and prostaglandins (PGE2, 6-keto-PGF1 alpha, and thromboxane B2 [TxB2]). The clearance of beta 2-microglobulin was used as indicator of the effective peritoneal surface area. The intrinsic permeability was characterized functionally by the peritoneal restriction coefficient. All protein clearances were increased during the acute phase of peritonitis and subsequently decreased to control. Likewise, the intrinsic peritoneal permeability was elevated, as demonstrated by a decrease of the peritoneal restriction coefficient. Peritoneal appearance rates of TNF-alpha, IL-6, and prostaglandins were also increased during the acute phase. Peak values were reached on day 1. The largest increase was observed for IL-6 (median 854-fold), followed by TNF-alpha (35-fold). The vasodilating PGE2 and 6-keto-PGF1 alpha were increased 12-fold and the vasoconstricting TxB2 was increased threefold. Evidence was obtained for local intraperitoneal synthesis of IL-6 and prostaglandins. TNF-alpha production appeared to be present only during the early acute inflammatory response. Analysis of variance for repeated measurements revealed that changes in the clearance of beta 2-microglobulin were related to those in IL-6 and marginally also to TNF-alpha in dialysate. Changes in the peritoneal restriction coefficient were also related to IL-6, but were more closely related to alterations in dialysate PGE2. These findings suggest that TNF-alpha, IL-6, and PGE2 are involved in the changes in permeability characteristics during CAPD-related peritonitis.

摘要

已知感染反应包括血管通透性和炎症介质的变化。我们将并发持续性非卧床腹膜透析(CAPD)的腹膜炎作为体内炎症模型,以研究腹膜通透性特征和透析液中介质的时间进程。从感染开始连续八天对16例腹膜炎发作进行前瞻性随访,并在恢复后进行一次检查(对照)。检查透析液夜间驻留液中的腹膜通透性标记蛋白、细胞因子(肿瘤坏死因子-α [TNF-α]、白细胞介素-6 [IL-6])和前列腺素(PGE2、6-酮-PGF1α和血栓素B2 [TxB2])。β2-微球蛋白的清除率用作有效腹膜表面积的指标。固有通透性通过腹膜限制系数进行功能表征。在腹膜炎急性期,所有蛋白质清除率均升高,随后降至对照水平。同样,腹膜固有通透性升高,表现为腹膜限制系数降低。TNF-α、IL-6和前列腺素的腹膜出现率在急性期也升高。在第1天达到峰值。观察到IL-6升高幅度最大(中位数854倍),其次是TNF-α(35倍)。血管舒张性PGE2和6-酮-PGF1α升高12倍,血管收缩性TxB2升高3倍。获得了IL-6和前列腺素在腹膜内局部合成的证据。TNF-α的产生似乎仅在早期急性炎症反应期间存在。重复测量的方差分析显示,β2-微球蛋白清除率的变化与IL-6的变化相关,并且在一定程度上也与透析液中的TNF-α相关。腹膜限制系数的变化也与IL-6相关,但与透析液中PGE2的变化关系更密切。这些发现表明,TNF-α、IL-6和PGE2参与了CAPD相关腹膜炎期间通透性特征的变化。

相似文献

1
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.在持续性非卧床腹膜透析腹膜炎的长期随访中,肿瘤坏死因子-α、白细胞介素-6和前列腺素与大分子物质腹膜通透性的关系
J Lab Clin Med. 1993 Dec;122(6):686-96.
2
Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析腹膜炎期间腹腔内抑制环氧化酶对透析液中炎症介质及腹膜特性的影响
J Lab Clin Med. 1995 Aug;126(2):204-15.
3
Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.持续性非卧床腹膜透析(CAPD)治疗患者在显性腹膜炎发作前不久对炎症介质及腹膜对大分子物质通透性的分析。
Perit Dial Int. 1995;15(2):134-41.
4
Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.持续性非卧床腹膜透析治疗患者腹膜炎期间的白细胞介素-8;急性炎症的体内模型
Nephrol Dial Transplant. 1994;9(2):169-74.
5
Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.无腹膜炎的持续性非卧床腹膜透析患者体内的白细胞介素-6:与腹膜内在通透性的关系
Clin Nephrol. 1992 Feb;37(2):97-103.
6
Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者腹膜炎期间前列腺素介导的蛋白质丢失
Kidney Int. 1986 Feb;29(2):584-90. doi: 10.1038/ki.1986.38.
7
Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?氨基酸基透析液对稳定期持续性非卧床腹膜透析患者腹膜血流及通透性的影响:一氧化氮的潜在作用?
Clin Nephrol. 1996 May;45(5):295-302.
8
Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?磷脂酶A2和一氧化氮是否参与持续性非卧床腹膜透析相关性腹膜炎时腹膜转运的改变?
J Lab Clin Med. 1998 Oct;132(4):329-40. doi: 10.1016/s0022-2143(98)90047-6.
9
Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.持续性转化生长因子β1表达可能预示频繁发生腹膜炎的腹膜透析患者发生腹膜纤维化。
Adv Perit Dial. 1997;13:64-71.
10
Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.持续性非卧床腹膜透析中的腹膜炎:腹膜液和血液中的细胞因子
Adv Perit Dial. 2002;18:177-83.

引用本文的文献

1
Peritoneal Protein Loss, Inflammation, and Nutrition: Refuting Myths.腹膜蛋白丢失、炎症与营养:破除误解
Front Med (Lausanne). 2022 May 26;9:884061. doi: 10.3389/fmed.2022.884061. eCollection 2022.
2
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites.肝硬化伴腹水患者腹腔内凝血和纤溶激活。
Thromb Haemost. 2022 Mar;122(3):353-362. doi: 10.1055/a-1515-9529. Epub 2021 Jul 4.
3
Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.
超滤失败反映了接受腹膜透析治疗患者的腹膜改变。
Front Physiol. 2018 Dec 20;9:1815. doi: 10.3389/fphys.2018.01815. eCollection 2018.
4
Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model.中性 IgG2 与阴离子 IgG4 在 PD 中的转运:对电动模型的影响。
BMC Nephrol. 2018 Oct 29;19(1):299. doi: 10.1186/s12882-018-1104-1.
5
Administration of Intravenous Inf liximab for Prevention of Peritoneal Adhesions Formation in Rats.静脉注射英夫利昔单抗预防大鼠腹膜粘连形成的研究
Bull Emerg Trauma. 2015 Jul;3(3):97-103.
6
The Natural Time Course of Membrane Alterations During Peritoneal Dialysis Is Partly Altered by Peritonitis.腹膜透析期间膜改变的自然病程部分会因腹膜炎而改变。
Perit Dial Int. 2016 Jul-Aug;36(4):448-56. doi: 10.3747/pdi.2014.00215. Epub 2015 Nov 2.
7
Monitoring of the peritoneal membrane.腹膜监测
NDT Plus. 2008 Oct;1(Suppl 4):iv29-iv35. doi: 10.1093/ndtplus/sfn121.
8
The Mutual Relationship Between Peritonitis and Peritoneal Transport.腹膜炎与腹膜转运的相互关系
Perit Dial Int. 2016 Jan-Feb;36(1):33-42. doi: 10.3747/pdi.2014.00115. Epub 2014 Nov 13.
9
The first peritonitis episode alters the natural course of peritoneal membrane characteristics in peritoneal dialysis patients.首次腹膜炎发作会改变腹膜透析患者腹膜特性的自然病程。
Perit Dial Int. 2015 May-Jun;35(3):324-32. doi: 10.3747/pdi.2014.00277. Epub 2014 Apr 7.
10
Can effluent matrix metalloproteinase 2 and plasminogen activator inhibitor 1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients?在腹膜透析患者中,流出液基质金属蛋白酶 2 和纤溶酶原激活物抑制剂 1 可否作为腹膜膜改变的生物标志物?
Perit Dial Int. 2013 Sep-Oct;33(5):529-37. doi: 10.3747/pdi.2012.01063. Epub 2013 Sep 1.